Latest DEF 14A proxy statements

Akari Therapeutics is holding a general meeting on October 28, 2026, to seek shareholder approval for a significant increase in the number of ordinary shares available under its 2023 Equity Incentive Plan.

ResMed reports robust fiscal year 2026 results with 8% revenue growth, 17% EPS increase, and over $1.6 billion in free cash flow, alongside strategic acquisitions and significant capital returns to shareholders.

Sysco Corporation's 2026 Proxy Statement details robust fiscal year performance with $84.6 billion in sales and $4.61 adjusted EPS, alongside strategic initiatives like the Jetro acquisition and technology transformation.

Lightstone Value Plus REIT IV, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for December 14, 2026, to elect three directors and address other business.

Gold.com, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on November 12, 2026, to elect directors and vote on executive compensation.

HCW Biologics Inc. is holding a special meeting on November 17, 2026, to seek stockholder approval for the issuance of common warrants related to a July 29, 2026, private placement financing.

Modular Medical, Inc. has issued a proxy statement for its upcoming Annual Meeting of Shareholders on October 23, 2026, detailing proposals for director elections, equity plan amendments, and auditor ratification.

Research Solutions, Inc. has announced its Annual Meeting of Stockholders for November 16, 2026, to elect directors, ratify auditors, and vote on executive compensation.

SelectQuote, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for November 10, 2026, to be held virtually, with key proposals including the election of directors, ratification of auditors, executive compensation approval, and a significant reverse stock split proposal.

Consumer Portfolio Services, Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for October 27, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Healthcare AI Acquisition Corp. is holding its annual general meeting to seek shareholder approval for an extension of its deadline to complete a business combination, proposing to move the date from October 14, 2026, to October 14, 2027.

Aeluma, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for November 19, 2026, to elect a director and ratify auditor appointments.

AIM ImmunoTech Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for November 17, 2026, to elect directors, ratify auditors, and approve executive compensation.

Alpha and Omega Semiconductor Limited announces its 2026 Annual General Meeting, detailing proposals for director elections, executive compensation, and amendments to equity incentive and employee share purchase plans.

Kimball Electronics, Inc. announced its upcoming rebranding to Kimball Solutions, Inc. and the acquisition of Helvoet Polymer Technologies, signaling a strategic expansion into medical contract manufacturing and advanced polymer solutions.

The Este Lauder Companies Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing director elections, auditor ratification, executive compensation, and a shareholder proposal on plastic packaging.

Banzai International, Inc. is holding a special meeting on October 16, 2026, to vote on several proposals including an asset purchase, name change, equity plan amendment, and a reverse stock split authorization.

Electromed, Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for November 13, 2026, to be held virtually, and is seeking shareholder approval for an Employee Stock Purchase Plan.

H&R Block Inc. has issued its proxy statement for the November 10, 2026 Annual Meeting of Shareholders, detailing director nominations, executive compensation, and the proposed 2026 Long Term Incentive Plan.

ABVC BioPharma is holding a special stockholder meeting on October 28, 2026, to vote on approving a new equity incentive plan, ratifying past equity awards, and authorizing the issuance of stock for land acquisitions in Taiwan.

Broadridge Financial Solutions, Inc. has released its 2026 Proxy Statement, detailing proposals for the upcoming Annual Meeting of Stockholders, including director elections and executive compensation.

Change Agents Corporation has called a special meeting of stockholders to vote on seventeen proposals, primarily focused on approving various issuances of the company's common stock and amendments to its charter.

Amcor PLC's 2026 proxy statement highlights successful integration of Berry Global, exceeding synergy targets and demonstrating solid financial performance with a 13% increase in adjusted EPS.

eXoZymes Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, scheduled for November 13, 2026, to elect directors and ratify auditors.

Texas Ventures Acquisition III Corp is seeking shareholder approval to extend its deadline for completing a business combination from October 24, 2026, to July 24, 2027, to facilitate its potential merger with Plus Automation, Inc.

BioVie Inc. has issued a proxy statement detailing its 2026 Annual Meeting agenda, which includes the election of directors, ratification of auditors, and a significant amendment to its 2019 Omnibus Equity Incentive Plan to increase share availability.

CytoDyn Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for November 20, 2026, to be held virtually, with key proposals including director elections and advisory votes on auditor ratification and executive compensation.

Quetta Acquisition Corporation is holding a special meeting on October 8, 2026, to seek shareholder approval for an amendment to extend the deadline for consummating its initial business combination from October 10, 2026, to October 10, 2027.

Planet Green Holdings Corp. has issued a proxy statement detailing proposals for its upcoming Annual Meeting, including director elections, auditor ratification, and a significant Chairman loan conversion.

GRI Bio, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for November 4, 2026, to be held virtually, detailing proposals for director elections, auditor ratification, and amendments to its equity incentive plan.